ALX ONCOLOGY HOLDINGS INC. - COMMON STOCK
0.8301
14-March-25 16:00:09
15 minutes delayed
Stocks
-0.0013
-0.16%
Today's range
0.8294 - 0.8600
ISIN
N/A
Source
NASDAQ
-
06 Mar 2025 16:01:00 By Nasdaq GlobeNewswire
-
05 Mar 2025 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
27 Feb 2025 08:00:01 By Nasdaq GlobeNewswire
-
ALX Oncology to Host Virtual R&D Day on March 5, 2025
18 Feb 2025 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
22 Jan 2025 16:01:00 By Nasdaq GlobeNewswire
-
21 Jan 2025 17:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 Jan 2025 08:00:01 By Nasdaq GlobeNewswire
-
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
12 Dec 2024 08:00:00 By Nasdaq GlobeNewswire
-
10 Dec 2024 09:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference
26 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
14 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
07 Nov 2024 16:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Announces November Investor Conference Participation
04 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
01 Nov 2024 17:30:00 By Nasdaq GlobeNewswire
-
ALX Oncology to Present at the 2024 Cantor Fitzgerald Global Healthcare Conference
09 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
08 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >